A
A
A

Local websites

Businesses

Other websites

General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

More information

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44
investor.relations@novartis.com

More information

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999
eric.althoff@novartis.com

More information

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Print
PDF

Shareholder information

Novartis ordinary shares

Find out more about the direct purchase of Novartis registered shares (for investors living in Switzerland) »
American Depository Shares (ADSs)

Find information for holders of Novartis American Depository Shares »
For Japanese investors

View specific information for Japanese investors, including translations of presentations »
Annual General Meeting

Find information about our Annual General Meeting »
Share buy-back

Find information about the current Novartis share buy-back program »

Top links

Top downloads

Stock chart

Stock performance

Q1 results 2013

Novartis announced its results for the first quarter of 2013 on April 24 ›

Novartis country websites:

Novartis business websites:

Worldwide offices

Select an office Select an office

Follow us

Novartis on Flickr

Stay up-to-date

© 2013 Novartis AG Terms of use Privacy policy Sitemap